ClinicalTrials.gg
Not yet recruitingNCT06893289Updated Nov 9, 2026

Proprioceptive Versus Strengthening Exercises for Patellofemoral Pain

An interventional study of Exercise and Muscle strengthening in Patellofemoral Pain, sponsored by Universidade do Porto. Not yet recruiting at 1 site in Portugal. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Universidade do Porto · Not applicable, Interventional, and Treatment

Updated Nov 9, 2026Title changedStart date moved+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Patellofemoral Pain (PFP) is one of the most common causes of knee pain and is significantly present in recreational athletes who have previously been categorized as being in a subgroup of PFP. Understanding which intervention is most appropriate for this subgroup could give us important information about subgroup-based treatments, which are not yet described in the literature. Therefore, the aim of this study is to analyze the effect of two exercise interventions in a PFP subgroup: one focusing on neuromuscular control exercises and the other focusing on muscle strengthening.This study will recruit 10 individuals to each exercise group, and will assess pain, function, muscle activity and joint kinematics pre and post intervention. Mixed Model ANOVA tests will be used to determine the responses to the two interventions between the two groups over a 6-week treatment time.

Read the detailed description

This study proposes a treatment protocol focused on neuromuscular control in a subgroup of individuals with PFP and may provide important information on the effectiveness of different treatment approaches for patellofemoral pain. It would be interesting to establish objectives according to clinical findings, and thus identify the best treatment protocols for specific subgroups of PFP. For a long time, the focus of rehabilitation has been on decreasing knee pain and strengthening the muscles around the knee to improve knee joint function (Piva et al., 2009) in a generalized way for all individuals with PFP. However, with recent information in the literature on the presence of subgroups, a study with a treatment protocol focused on neuromuscular control directed at a subgroup has not yet been carried out, which is the objective of this work. Thus, the hypothesis to be tested is that individuals from a PFP subgroup will present better results with neuromuscular control exercises than those performing muscle strengthening in the same treatment period.

The aim of this study is to compare the effects of two 6-week treatment protocols a) based on neuromuscular control exercises, and b) muscle strengthening on outcome measures of pain, function and biomechanical variables in a subgroup of individuals with PFP during stair ascent and descent.

-Detailed Description This study will be carried out at the Porto Biomechanics Laboratory (LABIOMEP) and at the gym of the Faculty of Sports (FADEUP) of University of Porto. The recruitment of volunteers for this project will take place in the city of Porto, Portugal. Participants will be invited to participate in the study if they self-report anterior knee pain exacerbated during a squatting test and/or during any sporting practice. Folders with all the information necessary for recruitment will be distributed among the academic and general community, recreational athletes during sporting events and on social media.

Sample calculation A sample size calculation was performed based on the minimal detectable change on the Visual Analog Pain Scale (VAS). Data from a previous study indicate that the mean VAS score in patients with PFP was 4.3 ± 1 cm (Crossley et al. 2004), with 30% of the maximum score of the VAS-pain considered to be the detectable change. The sample size for each group to achieve a 90% power at the 0.05 level of significance was determined to be 8 patients. Thus, the sample will consist of 20 volunteers (ten per group) of both sexes diagnosed with PFP.

Inclusion criteria Men and women aged 18-40 years old that can give informed written consent. Clinical diagnosis of unilateral or bilateral PFP longer than 3 months (exemplified in the following sections).

Anterior or retropatellar pain reported on at least two of the following activities: prolonged sitting, ascending or descending stairs, running, kneeling and hopping/jumping.

At least two of the three following clinical examination findings:

  • Pain during resisted isometric quadriceps contraction
  • Pain with palpation of the posterior borders of the patella
  • Pain during squatting Classified as a subgroup of PFP (exemplified in the following sections).

Exclusion criteria Individuals who are not part of a PFP group Previous knee surgery and participants awaiting surgery for another lower limb joint problem Ligamentous instability and/or internal pathology History of patella subluxation or dislocation Joint effusion when the midpatellar girth is 5% or more than the non-involved knee True knee joint locking and/or giving way Coexistent acute illness or chronic disease Bursitis, patella or iliotibial tract tendinopathy, Osgood-Schlatter's disease, Sinding-Larsen-Johansson Syndrome, muscle tears or symptomatic knee plicae Pregnancy or breast feeding

Clinical diagnosis of PFP The specific diagnosis of PFP will be made according to the recommendations of the Clinical Practice Guideline of Patellofemoral Pain (Willy et al. 2019).

  1. the presence of retropatellar or peripatellar pain,
  2. reproduction of retropatellar or peripatellar pain with squatting, stair climbing, prolonged sitting, or other functional activities loading the patellofemoral joint in a flexed position, and
  3. exclusion of all other conditions that may cause anterior knee pain, including tibiofemoral pathologies.

Also, the patellar tilt test will be used to verify mobility of the patella to support the diagnoses.

Clinical classification of a subgroup of PFP The classification into subgroups will be performed using the six clinical tests described by Selfe et al. 2016. The therapist manual of the Target Intervention for Patellofemoral Pain Syndrome (TIPPS) was made available by the authors of the original study and will be used as a guide to stratify individuals with PFP.

The first day of pre-intervention assessments will be carried out at the gym of the Faculty of Sports (FADEUP) of University of Porto. A physical therapist will access sociodemographic, anthropometric and contact data from each patient through an evaluation form. In no field of the evaluation form will the participant be identified. Baseline data will be collected following the recommendations of the REPORT-PFP checklist of items recommended for quantitative studies with individuals with PFP (Barton et al. 2021). The instruments that will be used to collect baseline symptoms are described in the following table. The administration method of all instruments that will be used to assess baseline symptoms is self-reportable.

Then, eligibility criteria, clinical diagnosis of PFP, and classification of subgroup according to the previous sections will be verified. The affected/most affected limb will be evaluated. All data from the first day of assessment will be analyzed and the individual will be invited to the second day of assessment only if they meet the eligibility criteria. If the individual is interested in participating, they will be asked to sign the informed consent form on the second day of pre-intervention assessment.

The second day of pre-intervention assessment will be carried out at the Porto Biomechanics Laboratory (LABIOMEP) of the University of Porto. The individual will sign the informed consent form and will then be prepared for the collection of kinetic and kinematic data. These data will be collected during stair ascent-descent.

Kinematic data will be recorded using a 3D motion capture system (three Oqus 310+ and nine Oqus 400 Qualisys infrared cameras, AB, Gothenburg, Sweden), sampling at 100 Hz. Thus, to obtain a three-dimensional (3D) biomechanical model, the 3D trajectories of passive retro-reflective markers will be captured. For the placement of the markers, the Calibrated Anatomical System Technique that allow for segmental kinematics to be tracked in 6-degrees of freedom will be used. It will be positioned on the anterior superior iliac spine, posterior superior iliac spine, greater trochanter, medial and lateral femoral epicondyles, medial and lateral malleoli, the medial aspect of the head of the 1st metatarsal, the lateral aspect of the head of the 5th metatarsal, the dorsum of the foot and the calcaneus. Additionally, clusters of four noncollinear markers will be attached to each of the body segments (Richards et al. 2018).

For kinetic data, a four-step staircase with a force platform embedded on each step will be used (two Bertec, OH, USA and two AMTI, MA, USA) sampling at 2000 Hz. The steps have a riser height of 17 cm, run of 25 cm, and width of 60 cm.

Electromyography evaluation will be made with four dEMG Delsys Trigno Wireless sensors positioned over the Vastus Medialis (VM) and Vastus Lateralis (VL) muscles of both limbs. The positioning of the electrodes will be carried out according to SENIAM - Surface Electromyography for the Non-Invasive Assessment of muscles (Hermens et al., 2000).

In the revaluation, the baseline symptoms (pain, function, kinesiophobia, IPAQ, GROC), biomechanical and electromyography assessments will be performed again.

Randomization The stratified randomization method will be performed to balance the two treatment groups according to gender (Kang, Ragan, e Park 2008). Randomization will be performed after baseline and biomechanical assessments, and patients will be blinded to group allocation, ensuring that they will not know which exercises will be performed by the other group, and thus the interventions will be administered separately to members of each treatment group (Baldon et al. 2014).

Treatment protocols The individuals will be separated into two groups: group 1 (G1) - usual treatment group; and group 2 (G2) - neuromuscular control exercise group. Both groups will undergo 6 weeks of treatment, with 3 sessions of 60 minutes per week (Yosmaoğlu et al. 2019). In each session, 10 minutes of warm-up will be performed before the start of the intervention.

During the study period, volunteers will be asked not to seek another type of treatment for knee pain and to maintain their regular daily activities. Each volunteer will be supervised by a researcher trained specifically for the treatment under study. The Template for Intervention Description and Replication (TIDieR) will be used to describe the interventions (Hoffmann et al. 2014). If patients report severe pain at any point, the intensity of the exercise will be reduced so that they can perform the movement without pain.

Intended statistical analysis Descriptive statistics of means and standard deviations will be obtained for each outcome measure. Shapiro-Wilk tests will be used to screen the data for normality. Differences in biomechanical and knee pain parameters will be examined using 2 (pre-post intervention) x2 (subgroup) Mixed Model ANOVA tests. Statistical significance will be accepted at the P≤0.05 level. Effect sizes will be calculated using partial Eta2 (pη2). Effect sizes will be contextualized using the following guidelines: small = 0.01, medium = 0.06 and large = 0.14 (Cohen, 1988). All statistical analysis will be performed using SPSS v24.0 (SPSS Inc, Chicago, USA).

02

Conditions studied

  • Patellofemoral Pain

Keywords

  • Patellofemoral pain
  • Electromyography
  • Kinematics
  • Kinetics
  • Neuromuscular control
  • PFP subgroups
03

In context

Patellofemoral Pain Syndrome

297 studies on the registry are indexed under Patellofemoral Pain Syndrome; 74 are open to participants now.

This study's planned enrollment of 24 is below the median of 45 across 244 interventional studies indexed under Patellofemoral Pain Syndrome.

Browse Patellofemoral Pain Syndrome studies →

Lead sponsor

Universidade do Porto is the lead sponsor of 174 studies on the registry; 53 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Oct 6, 2026. See what changed

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Men and women aged 18-40 years old that can give informed written consent. Clinical diagnosis of unilateral or bilateral PFP longer than 3 months (exemplified in the following sections).

Anterior or retropatellar pain reported on at least two of the following activities: prolonged sitting, ascending or descending stairs, running, kneeling and hopping/jumping.

At least two of the three following clinical examination findings:

  • Pain during resisted isometric quadriceps contraction
  • Pain with palpation of the posterior borders of the patella
  • Pain during squatting Classified as being within the strong subgroup of PFP (exemplified in the following sections).

Exclusion criteria

Exclusion Criteria:

  • Individuals who are not part of the 'strong' PFP group
  • Previous knee surgery and participants awaiting surgery for another lower limb joint problems
  • Ligamentous instability and/or internal pathology
  • History of patella subluxation or dislocation
  • Joint effusion when the midpatellar girth is 5% or more than the non-involved knee
  • True knee joint locking and/or giving way
  • Coexistent acute illness or chronic disease
  • Bursitis, patella or iliotibial tract tendinopathy, Osgood-Schlatter's disease, -Sinding-Larsen-Johansson Syndrome, muscle tears or symptomatic knee plicae
  • Pregnancy or breast feeding
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Neuromuscular control exercises

    Other: Exercise

  • Active comparator
    Muscle strengthening

    Other: Muscle strengthening

Interventions

  • OtherExercise

    Balance and proprioceptive exercises

  • OtherMuscle strengthening

    Strengthening of the lower limb muscles

06

What researchers measure

Primary outcomes

  1. Pain intensity

    Full name: Numerical Pain Rating Scale (NPRS) Minimum value: 0; Maximum value: 10. Direction: Higher scores indicate a worse outcome, that is, greater pain intensity. Interpretation: 0: no pain 1-3: mild pain 4-6: moderate pain 7-10: intense/severe pain

    Time frame: From enrollment to the end of treatment at 6 weeks

Secondary outcomes

  1. Specific Knee Function

    Full name: Anterior Knee Pain Scale (AKPS) Minimum value: 0 Maximum value: 100 Direction: higher scores indicate a better outcome (fewer symptoms and better knee function). General interpretation: 100 represents an absence of limitations/symptoms, while 0 represents greater functional impairment.

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. General function

    Full name: Knee injury and Osteoarthritis Outcome Score - Physical Function Shortform (KOOS-PS) Minimum value: 0 Maximum value: 100 Direction: higher scores indicate a worse outcome (greater difficulty/limitation in physical function). Interpretation: 0 = no functional difficulty; 100 = extreme functional difficulty.

    Time frame: From enrollment to the end of treatment at 6 weeks

  3. Kinesiophobia

    Full name: Tampa Scale for Kinesiophobia (TSK-13) Number of items: 13 Minimum score: 13 Maximum score: 52 Direction: higher scores indicate a worse outcome, corresponding to a greater fear of movement/re-injury (kinesiophobia).

    Time frame: From enrollment to the end of treatment at 6 weeks

  4. Pain Catastrophizing

    Full name: Pain Catastrophizing Scale (PCS) Number of items: 13 Minimum score: 0 Maximum score: 52 Direction: higher scores indicate a worse outcome, corresponding to a higher level of pain catastrophizing.

    Time frame: From enrollment to the end of treatment at 6 weeks

  5. Knee angles

    Motion capture system

    Time frame: From enrollment to the end of treatment at 6 weeks

  6. Knee moments

    Force platforms and cameras

    Time frame: From enrollment to the end of treatment at 6 weeks

  7. Muscular activity

    Electromyography system

    Time frame: From enrollment to the end of treatment at 6 weeks

07

Study locations

1 site
  • Faculty of Sport of University of Porto
    Porto, 4200-450, Portugal
    • Ana Luiza Costa e Silva Cabral · Contactanaluizacsc@gmail.com · 934718655
    • · Contactanaluizacsc@gmail.com
    • Ana Luiza Costa e Silva Cabral, Master's degree · Principal investigator
    • João Paulo Vilas-Boas, Full professor · Principal investigator
    • Jim Richards, Full professor · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

2 registry updates since Sep 25, 2026
Start date
Oct 1, 2026→Oct 12, 2026
Oct 6, 2026
Eligibility
1 inclusion criterion edited; 1 exclusion criterion edited; 1 criterion removed
What changed in the criteria
  • RemovedExclusion Criteria
Inclusion criteria
  • EditedInclusion Criteria Men and women aged 18-40 years old that can give informed written consent. Clinical diagnosis of unilateral or bilateral PFP longer than 3 months (exemplified in the following sections).
Exclusion criteria
  • EditedIndividuals who are not part of athe 'strong' PFP group
Oct 6, 2026
Title
The Effect of a Treatment Protocol Focused on Neuromuscular Control Exercises on Pain and Function in a Subgroup of Individuals With Patellofemoral Pain→Proprioceptive Versus Strengthening Exercises for Patellofemoral Pain
Nov 9, 2026
Show all 2 updates
  1. Nov 9, 2026
    Title The Effect of a Treatment Protocol Focused on Neuromuscular Control Exercises on Pain and Function in a Subgroup of Individuals With Patellofemoral Pain→Proprioceptive Versus Strengthening Exercises for Patellofemoral Pain
    + 1 other change: verification date
  2. Oct 6, 2026
    Start date Oct 1, 2026→Oct 12, 2026
    Eligibility 1 inclusion criterion edited; 1 exclusion criterion edited; 1 criterion removed
    What changed in the criteria
    • RemovedExclusion Criteria
    Inclusion criteria
    • EditedInclusion Criteria Men and women aged 18-40 years old that can give informed written consent. Clinical diagnosis of unilateral or bilateral PFP longer than 3 months (exemplified in the following sections).
    Exclusion criteria
    • EditedIndividuals who are not part of athe 'strong' PFP group
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06893289
Responsible party
Ana Luiza Costa e Silva Cabral (PhD candidate, Universidade do Porto) — Principal investigator
First posted
Mar 25, 2025
Start date
Oct 12, 2026 (estimated)
Primary completion
Nov 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Nov 9, 2026

Study contacts

Ana Luiza Costa e Silva Cabral, Master in Physiotherapy
Contact
analuizacsc@gmail.com
+351934718655
João Paulo Vilas-Boas, Full professor
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion